Align Technology (NASDAQ: ALGN) has recently been downgraded from a “buy” rating to a “hold” rating by analysts at StockNews.com. Other equities research analysts have also provided various ratings for the company, with price targets ranging from $300 to $350. The company’s stock opened at $220.45 on Thursday, with a 12 month low of $176.34 and a high of $413.20.
In their most recent quarterly earnings report, Align Technology reported earnings per share of $2.41, surpassing the consensus estimate. The company’s revenue was slightly below analyst expectations, leading to a mix of ratings from analysts. Overall, the company currently holds a consensus rating of “hold” with an average price target of $330.50.
Institutional investors have shown interest in Align Technology, with several hedge funds and investment firms increasing their holdings in the company. Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners for orthodontists and dentists globally. The firm’s Clear Aligner segment includes products tailored for younger patients, offering a variety of comprehensive packages.
While the recent downgrade may have raised concerns among investors, the company’s solid earnings performance and continued interest from institutional investors suggest ongoing growth potential. As Align Technology navigates through market fluctuations, investors will be keeping a close eye on future developments and earnings reports to gauge the company’s performance and potential for long-term profitability.
Source
Photo credit www.defenseworld.net